ReviewApoptosis : an international journal on programmed cell death2026
Cell death network regulation in HSV infection: immune evasion versus host defense.
Review in Apoptosis : an international journal on programmed cell death, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herpes simplex virus type 1 (HSV-1) causes prevalent infections ranging from orolabial lesions to keratitis and encephalitis, with virus-host interplay around cell death pathways critically determining disease outcomes. This review systematically examines how HSV-1 dynamically manipulates programmed cell death processes-including apoptosis, pyroptosis, necroptosis, autophagy, and ferroptosis-through multiple viral proteins to evade immune clearance, facilitate replication, or maintain latency. Concurrently, host DNA sensors such as AIM2 and IFI16 activate inflammasomes and the PANoptosome to trigger coordinated cell death that restricts viral spread; imbalances in this bidirectional regulation exacerbate tissue damage in skin, cornea, and central nervous system, driving neuroinflammation and blood-brain barrier disruption. Elucidating these mechanisms not only uncovers novel principles of HSV-1 pathogenesis and immune evasion but also informs antiviral therapies and the rational design of oncolytic HSV-1 vectors.
Indexed as
Identifiers
42671474What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.